OUT. 9th, 2021 | Online Event
The 3rd edition of the Biotechnology Innovation Forum: Think Big in Biotechnology, under the theme “Fostering SMART Innovation Synergies” highlights the need for collaboration and innovation in multiple areas of Biotechnology in order to face the many challenges that lie ahead in a soon to be post-pandemic world.
The first panel ‘From a Healthy Economy to an Economy of Health’, will focus on discussing new strategies that promote more reliable and resilient health systems, targeting the visible difficulties that health systems surpassed in the COVID19 pandemic. The second session entitled ‘’Law, Ethics and Biotechnology in AI’ will focus on discussing the ethical dilemmas that have risen from the progress powered by artificial intelligence technology. After a brief online coffee break, the panel titled ‘Science Literacy and Disinformation in the Era of Social Media’ will discuss the spread of misinformation and wrongful notions of ‘scientific evidence and the best strategies to combat this rising issue in the era of social media. Last but not least, an executive panel will discuss ‘The Role of Open Innovation in Sustainable Development’, seeking to underline the utmost importance of open innovation as a vehicle for value creation. This year's edition will also be characterized by a unique Biotechnology Contest, “Amyris Innovation BIG Impact Award”, that focuses on biotechnological developments that have Sustainability concepts at their core, with a major impact on Society.
Join us online on Saturday, 9th October 2021.
The 3rd edition of the Biotechnology Innovation Forum: Think Big in Biotechnology, will host for the first time the Amyris Innovation BIG Impact Award, an Innovation Contest in Biotechnology promoted by the Católica Porto Alumni Biotecnologia, in partnership with the School of Biotechnology of Universidade Católica Portuguesa, and Amyris Inc, as its main sponsor. The Competition is based on the promotion of Biotechnology innovation as a key driver for economic development and it aims at promoting new processes, technologies, or services that are both marketable and sustainable, with BIG positive and measurable impacts on Society. Selected applications will benefit from a prize money together with a mentorship session with Amyris Inc. CEO, John Melo.
Submit your project until 22/07/2021.
If you would like to attend to the event, please fill in this form.
Part 1. FROM A HEALTHY ECONOMY TO AN ECONOMY OF HEALTH
Keynote Speaker Tiago Cravo Hashiguchi
Health policy analyst with a PhD in health Management and a Masters in Biomedical Engineering. Tiago has experience in consulting, academia and international policy, formal training in both qualitative and quantitative research methods, extensive practice disseminating complex data and ideas to technical and policy audiences, working in multidisciplinary teams with demanding objectives.
Round table (1) Filipa Fonseca
Filipa Fonseca has a PhD in Management Program from the Nova School of Business and Economics. Her main field of study has been healthcare services, medical errors,organizational safety, operations and service management. She holds an MBA from Catholic Porto Business School in collaboration with ESADE Business School Barcelona (2004-2005). Filipa is affiliate member of Nova Healthcare Initiative – Research (NHI) and knowledge center for Health Economics, Health Management, Health Policy, and Public Health. The center focuses on producing and disseminating scientific knowledge with the aim of being useful to Society and contributing to well-informed and well-reasoned decision-making.
Round table (2) Fernando Correia
Fernando Correia is physician specialized in Neurology and trained in Portugal and in the UK (National Hospital for Neurology and Neurosurgery and Great Ormond Street Hospital for Children), and Fellow of the European Board of Neurology since 2015. He also holds an Executive Masters degree in Health Management. Fernando is Chief Medical Officer at SWORD Health, a digital health company that is re-defining musculoskeletal care from the ground up, where he leads the clinical validation and medical affairs departments.
Moderator Luís Rebelo
Luís Pina Rebelo is a professor at Católica Porto Business School. He holds a PhD in Economics with a specialization in Health Economics and Management. His research interests focuses on Health Economics and Management, namely on issues related to Sustainability and Health, Health and Welfare, Public Health Assessment, Hospital Efficiency and Management of Health Units, Health and Economic Growth and Econometrics Applied to Health. In this sense, he has had several interventions in international conferences (eg, iHEA, IEA), being a member of the Portuguese Association of Health Economics (APES). He is responsible for the discipline of "PF-Business Plan", having developed several projects in the Real Estate Sector, after having held the position of Marketing Director for some years, and later Director of a Real Estate Management and Promotion firm.
Part 2. LAW, ETHICS AND BIOTECHNOLOGY IN AI
Keynote Chhavi Chauhan
Researcher with a doctoral degree in Molecular Biology and Masters in Biotechnology with a commitment to effective communication around complex matters to diverse audiences. Currently she is the director of Journal Continuing Medical Education Program and a chapter leader of the Women in AI Ethics
Round table (1) Filipa Calvão
Law degree from the Catholic University of Portugal, in 1993. Master of Law in the area of Political Legal Sciences, from University of Coimbra, in 1997. Doctor of Law in the area of Legal Sciences Policies, by the Faculty of Law of the University of Coimbra, in 2009. President of the National Data Protection Commission, since 2012.
Round table (2) Idoia Salazar
Co-founder and president of the Observatory of the Social and Ethical Impact of Artificial Intelligence (OdiseIA). She is Principal Investigator of the SIMPAIR Research Group (Social Impact of Artificial Intelligence and Robotics) , focusing mainly on the need for a multicultural approach to Ethics in AI. She is specialist in Ethics in Artificial Intelligence, professor in international degrees at CEU San Pablo University. She is in the list of experts to assist the European Parliament´s Artificial Intelligence Observatory (EPAIO); member of the Board of Directors of the Association ‘Arco Atlántico para la Seguridad y el entorno Digital’; founding member of Springer AI and Ethics journal and member of the Global AI Ethics Consortium.
Round table (3) Patrícia Xufre
Patrícia Xufre is Assistant Professor of Quantitative Methods. She holds a PhD in Statistics and Operations Research from the Faculty of Science of the University of Lisbon, focusing on Neurocomputational methods to support trading decisions systems. She has earned her Master in Operations Research from the Faculty of Sciences of the University of Lisbon. She is a published author on AI focused themes such as "Investment strategies based on supervised learning" and "Neuro-dynamic trading methods".
Moderator Raquel Carvalho
Raquel Maria Resende Duarte de Carvalho. Completed the PhD in Law in 2009 by Faculdade de Direito da Universidade Católica, Master's degree in Law, in 1999 by Universidade de Coimbra and Undergraduate in Law in 1994 by Universidade Católica Portuguesa (5 years). She is a Associate Professor in Universidade Católica Portuguesa Faculdade de Direito Escola do Porto. Founding member of EUROPEAN ASSOCIATION OF PUBLIC-PRIVATE PARTNERSHIP – E.A.P). Member of the Portuguese Section of Réseau Académique sur la Charte Sociale Européenne et les Droits Sociaux. Member of the RED Iberoamericana de Contratación Pública and European Law Institute.
Part 3. SCIENCE LITERACY & DISINFORMATION IN THE ERA OF SOCIAL MEDIA
Mário Augusto began his career as a journalist in 1985, interning at the newspaper O Comércio do Porto, later collaborating in the weekly Sete and several other magazines. He also worked at Rádio Comercial, at RDP Antena1 and joined the founding team of Rádio Nova, from Porto. In 1987 he joined the Information Department of RTP, where he remained until 1992. He currently works at RTP.
Carlos Brito is vice-rector of Portucalense University, president of the Observatory of Port Wine, vice-president of the Portuguese Management Association, member of advisory boards of COTEC Portugal, SEDES, INOV.ORG, APCER, Sigma and Essência Completa, and member of the International Board of Advisors for Strategy Implementation of the Silesian University of Technology. He was Pro-Rector of Innovation and Entrepreneurship and Director of UPTEC - Science and Technology Park.
Graduated in Economics with an MBA and PhD in Marketing. He has complimentary education in Entrepreneurship & Innovation and Education Leadership.
Part 4. THE ROLE OF OPEN INNOVATION IN SUSTAINABLE DEVELOPMENT
Keynote John Melo
John G. Melo is CEO of Amyris Biotechnologies, a world leader company in industrial biotechnology applications, working to reduce the coast of healing malaria and the carbon low production, the second generation of biofuels.
Previously, he was the President of USA BP Fuels, where he led the major oil marketing, logistics and trade business.
Beforehand he was Director of Ernst & Young, in San Jose, California, and a member of the management team in many startups in the north of California, including Computer Aided Services and Alldata Corporation.
Round table (1) António Vasconcelos
António Vasconcelos is Management Director at NEW-NEXT, co-leader at Planetiers New Generation, and coordinator at the International Board of The Natural Step, a pioneer effort with almost 30 years of experience in supporting progressive leaders to integrate business development with the pursuit of full sustainability (economic, environmental, and social).
He has been at the forefront of multidisciplinary advisory teams to support organizational transformation efforts - both for business relevance (New Next Moves) and sustainability (New Next Futures).
Moderator Manuela Pintado
Manuela Pintado is Associate Professor, and Director of the Centre for Biotechnology and Fine Chemistry (CBQF). She is the leader of Biobased and Biomedical products group and coordinates the Bioactives and Bioproducts Research Laboratory. Her main areas of research include development and characterization of bioactives and by-product valorization through bioprocesses and extraction processes aiming to obtain high-added value products to be applied to Food and other industries. She co-authored ca. 400 papers in international journals, a creator of 20 patents, has been involved in the supervision/co-supervision of 34 concluded PhD theses, and coordinated/co-coordinated ca. 90 externally funded projects.